Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Soiken Holdings Inc
2385Soiken Holdings Inc. engages in the development of biomarkers in Japan. The company is involved in the development and sale of cosmetics and dietary supplements comprising imidapeptides; licensing and development of biomarker technology; provision of marketing research and post-marketing surveys for dietary supplements; and research, development, and sale of functional materials, such as lactoferrin, as well as pharmaceutical products from ascochlorin derivatives. It also provides clinical evaluation tests for foodstuffs using biomarker technology; support for pharmaceutical clinical research and epidemiology studies; and services to health insurance societies, including contracted health guidance, specific health checkup promotion services for the dependents of insured, and service to prevent diabetes. The company was incorporated in 1994 and is headquartered in Toyonaka, Japan. Address: Senri Life Science Center, Toyonaka, Japan, 560-0082
Analytics
Objectif de Cours de WallStreet
93 431.85 JPYRatio C/B
–Rendement du dividende
3.66 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés 2385
Analyse des dividendes 2385
Croissance des dividendes sur 5 ans
150 %Croissance continue
–Ratio de distribution Moyenne sur 5 ans
20 %Historique des dividendes 2385
Valorisation des titres 2385
financières 2385
Résultats | 2019 | Dynamique |